Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Be ever cautious until the truth is proven.

Chantepie S, Yakoub-Agha I, Damaj G.

Am J Hematol. 2019 Jan 21. doi: 10.1002/ajh.25410. [Epub ahead of print] No abstract available.

PMID:
30663789
2.

[Prophylaxis of infections post-allogeneic transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

Lewalle P, Pochon C, Michallet M, Turlure P, Brissot E, Paillard C, Puyade M, Roth-Guepin G, Yakoub-Agha I, Chantepie S.

Bull Cancer. 2019 Jan;106(1S):S23-S34. doi: 10.1016/j.bulcan.2018.08.017. Epub 2019 Jan 4. Review. French.

PMID:
30616839
3.

A heparan sulfate-based matrix therapy reduces brain damage and enhances functional recovery following stroke.

Khelif Y, Toutain J, Quittet MS, Chantepie S, Laffray X, Valable S, Divoux D, Sineriz F, Pascolo-Rebouillat E, Papy-Garcia D, Barritault D, Touzani O, Bernaudin M.

Theranostics. 2018 Nov 12;8(21):5814-5827. doi: 10.7150/thno.28252. eCollection 2018.

4.

Glycosaminoglycans from Alzheimer's disease hippocampus have altered capacities to bind and regulate growth factors activities and to bind tau.

Huynh MB, Ouidja MO, Chantepie S, Carpentier G, Maïza A, Zhang G, Vilares J, Raisman-Vozari R, Papy-Garcia D.

PLoS One. 2019 Jan 4;14(1):e0209573. doi: 10.1371/journal.pone.0209573. eCollection 2019.

5.

SLC10A7 mutations cause a skeletal dysplasia with amelogenesis imperfecta mediated by GAG biosynthesis defects.

Dubail J, Huber C, Chantepie S, Sonntag S, Tüysüz B, Mihci E, Gordon CT, Steichen-Gersdorf E, Amiel J, Nur B, Stolte-Dijkstra I, van Eerde AM, van Gassen KL, Breugem CC, Stegmann A, Lekszas C, Maroofian R, Karimiani EG, Bruneel A, Seta N, Munnich A, Papy-Garcia D, De La Dure-Molla M, Cormier-Daire V.

Nat Commun. 2018 Aug 6;9(1):3087. doi: 10.1038/s41467-018-05191-8.

6.

New tools for carbohydrate sulfation analysis: heparan sulfate 2-O-sulfotransferase (HS2ST) is a target for small-molecule protein kinase inhibitors.

Byrne DP, Li Y, Ramakrishnan K, Barsukov IL, Yates EA, Eyers CE, Papy-Garcia D, Chantepie S, Pagadala V, Liu J, Wells C, Drewry DH, Zuercher WJ, Berry NG, Fernig DG, Eyers PA.

Biochem J. 2018 Aug 14;475(15):2417-2433. doi: 10.1042/BCJ20180265.

7.

The role of heparan sulfates in protein aggregation and their potential impact on neurodegeneration.

Maïza A, Chantepie S, Vera C, Fifre A, Huynh MB, Stettler O, Ouidja MO, Papy-Garcia D.

FEBS Lett. 2018 Dec;592(23):3806-3818. doi: 10.1002/1873-3468.13082. Epub 2018 Jun 14. Review.

PMID:
29729013
8.

Eculizumab reversed severe distal ischemic syndrome and glomerulonephritis with isolated C3 deposits associated with anti-factor H autoantibodies: a case report.

Deshayes S, Martin Silva N, Chatelet V, Chantepie S, Le Quintrec M, Comoz F, Bridoux F, Dragon-Durey MA, Aouba A.

Clin Rheumatol. 2018 Apr;37(4):1119-1122. doi: 10.1007/s10067-018-4058-6. Epub 2018 Mar 7. Review.

PMID:
29516279
9.

Bendamustine-based conditioning prior to autologous stem cell transplantation (ASCT): Results of a French multicenter study of 474 patients from LYmphoma Study Association (LYSA) centers.

Chantepie SP, Garciaz S, Tchernonog E, Peyrade F, Larcher MV, Diouf M, Fornecker LM, Houot R, Gastinne T, Soussain C, Malak S, Lemal R, Delette C, Ibrahim A, Gac AC, Reboursière E, Vilque JP, Bekadja MA, Casasnovas RO, Gressin R, Guidez S, Coso D, Herbaux C, Yakoub-Agha I, Bouabdallah K, Durot E, Damaj G.

Am J Hematol. 2018 Jun;93(6):729-735. doi: 10.1002/ajh.25077. Epub 2018 Mar 14.

PMID:
29473209
10.

18F-Fludarabine PET for Lymphoma Imaging: First-in-Humans Study on DLBCL and CLL Patients.

Chantepie S, Hovhannisyan N, Guillouet S, Pelage JP, Ibazizene M, Bodet-Milin C, Carlier T, Gac AC, Réboursière E, Vilque JP, Kraeber-Bodéré F, Manrique A, Damaj G, Leporrier M, Barré L.

J Nucl Med. 2018 Sep;59(9):1380-1385. doi: 10.2967/jnumed.117.206920. Epub 2018 Feb 1.

PMID:
29419478
11.

Sequential Conditioning with Thiotepa in T Cell- Replete Hematopoietic Stem Cell Transplantation for the Treatment of Refractory Hematologic Malignancies: Comparison with Matched Related, Haplo-Mismatched, and Unrelated Donors.

Duléry R, Ménard AL, Chantepie S, El-Cheikh J, François S, Delage J, Giannotti F, Ruggeri A, Brissot E, Battipaglia G, Malard F, Belhocine R, Sestili S, Vekhoff A, Delhommeau F, Reman O, Legrand O, Labopin M, Rubio MT, Mohty M.

Biol Blood Marrow Transplant. 2018 May;24(5):1013-1021. doi: 10.1016/j.bbmt.2018.01.005. Epub 2018 Jan 11.

PMID:
29337223
12.

[Allogeneic haematopoietic cell transplantation for diffuse large B cell lymphoma: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

Gauthier J, Chantepie S, Bouabdallah K, Jost E, Nguyen S, Gac AC, Damaj G, Duléry R, Michallet M, Delage J, Lewalle P, Morschhauser F, Salles G, Yakoub-Agha I, Cornillon J.

Bull Cancer. 2017 Dec;104(12S):S131-S135. doi: 10.1016/j.bulcan.2017.10.018. Epub 2017 Nov 22. Review. French.

PMID:
29173980
13.

[Allogeneic hematopoietic cell transplantation for Hodgkin's disease, mantle cell lymphoma and other rare entities: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

Gauthier J, Chantepie S, Bouabdallah K, Jost E, Nguyen S, Gac AC, Damaj G, Duléry R, Michallet M, Delage J, Lewalle P, Morschhauser F, Salles G, Yakoub-Agha I, Cornillon J.

Bull Cancer. 2017 Dec;104(12S):S112-S120. doi: 10.1016/j.bulcan.2017.06.020. Epub 2017 Nov 23. French.

PMID:
29173978
14.

[Allogeneic haematopoietic cell transplantation for indolent lymphomas: Guidelines from the Francophone Society Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

Gauthier J, Chantepie S, Bouabdallah K, Jost E, Nguyen S, Gac AC, Damaj G, Duléry R, Michallet M, Delage J, Lewalle P, Morschhauser F, Salles G, Yakoub-Agha I, Cornillon J.

Bull Cancer. 2017 Dec;104(12S):S121-S130. doi: 10.1016/j.bulcan.2017.05.010. Epub 2017 Nov 22. Review. French.

PMID:
29173973
15.

[Use of alternative donors for allogeneic haematopoietic cell transplantation in lymphoid neoplasms: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

Gauthier J, Chantepie S, Bouabdallah K, Jost E, Nguyen S, Gac AC, Damaj G, Duléry R, Michallet M, Delage J, Lewalle P, Morschhauser F, Salles G, Yakoub-Agha I, Cornillon J.

Bull Cancer. 2017 Dec;104(12S):S106-S111. doi: 10.1016/j.bulcan.2017.08.008. Epub 2017 Nov 21. Review. French.

PMID:
29169650
16.

Small dense HDLs display potent vasorelaxing activity, reflecting their elevated content of sphingosine-1-phosphate.

Perségol L, Darabi M, Dauteuille C, Lhomme M, Chantepie S, Rye KA, Therond P, Chapman MJ, Salvayre R, Nègre-Salvayre A, Lesnik P, Monier S, Kontush A.

J Lipid Res. 2018 Jan;59(1):25-34. doi: 10.1194/jlr.M076927. Epub 2017 Nov 17.

17.

[Heparan sulphates, amyloidosis and neurodegeneration].

Vera C, Alvarez-Orozco JA, Maiza A, Chantepie S, Chehin RN, Ouidja MO, Papy-Garcia D.

Rev Neurol. 2017 Nov 16;65(10):457-468. Review. Spanish.

18.

Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.

Le Bourgeois A, Labopin M, Blaise D, Ceballos P, Vigouroux S, Peffault de Latour R, Marçais A, Bulabois CE, Bay JO, Chantepie S, Deconinck E, Daguindau E, Contentin N, Yakoub-Agha I, Cornillon J, Mercier M, Turlure P, Charbonnier A, Rorhlich PS, N'Guyen S, Maillard N, Marchand T, Mohty M, Chevallier P; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.

Ann Oncol. 2017 Sep 1;28(9):2191-2198. doi: 10.1093/annonc/mdx274.

PMID:
28911060
19.

Rituximab-based first-line treatment of cGVHD after allogeneic SCT: results of a phase 2 study.

Malard F, Labopin M, Yakoub-Agha I, Chantepie S, Guillaume T, Blaise D, Tabrizi R, Magro L, Vanhove B, Blancho G, Moreau P, Gaugler B, Chevallier P, Mohty M.

Blood. 2017 Nov 16;130(20):2186-2195. doi: 10.1182/blood-2017-05-786137. Epub 2017 Sep 1.

20.

Increased signaling by the autism-related Engrailed-2 protein enhances dendritic branching and spine density, alters synaptic structural matching, and exaggerates protein synthesis.

Soltani A, Lebrun S, Carpentier G, Zunino G, Chantepie S, Maïza A, Bozzi Y, Desnos C, Darchen F, Stettler O.

PLoS One. 2017 Aug 15;12(8):e0181350. doi: 10.1371/journal.pone.0181350. eCollection 2017.

21.

Effect of Azithromycin on Airflow Decline-Free Survival After Allogeneic Hematopoietic Stem Cell Transplant: The ALLOZITHRO Randomized Clinical Trial.

Bergeron A, Chevret S, Granata A, Chevallier P, Vincent L, Huynh A, Tabrizi R, Labussiere-Wallet H, Bernard M, Chantepie S, Bay JO, Thiebaut-Bertrand A, Thepot S, Contentin N, Fornecker LM, Maillard N, Risso K, Berceanu A, Blaise D, Peffault de La Tour R, Chien JW, Coiteux V, Socié G; ALLOZITHRO Study Investigators.

JAMA. 2017 Aug 8;318(6):557-566. doi: 10.1001/jama.2017.9938.

22.

Increased frequencies of circulating and tumor-resident Vδ1+ T cells in patients with diffuse large B-cell lymphoma.

Reboursiere E, Gac AC, Garnier A, Salaun V, Reman O, Pham AD, Cabrera Q, Khoy K, Vilque JP, Fruchart C, Chantepie S, Johnson-Ansah H, Macro M, Cheze S, Benabed K, Mear JB, Troussard X, Damaj G, Le Mauff B, Toutirais O.

Leuk Lymphoma. 2018 Jan;59(1):187-195. doi: 10.1080/10428194.2017.1321751. Epub 2017 May 31.

PMID:
28562153
23.

Conserved G-matrices of morphological and life-history traits among continental and island blue tit populations.

Delahaie B, Charmantier A, Chantepie S, Garant D, Porlier M, Teplitsky C.

Heredity (Edinb). 2017 Aug;119(2):76-87. doi: 10.1038/hdy.2017.15. Epub 2017 Apr 12.

24.

[Cutaneous involvement in T-lymphoblastic lymphoma].

Nascimbeni C, Chantepie S, Brugiere C, Comoz F, Salaun V, Verneuil L.

Ann Dermatol Venereol. 2017 Apr;144(4):268-274. doi: 10.1016/j.annder.2017.01.001. Epub 2017 Feb 24. French.

PMID:
28242092
25.

Hyper-CVAD + epratuzumab as a salvage regimen for younger patients with relapsed/refractory CD22-positive precursor B-cell acute lymphocytic leukemia.

Chevallier P, Chantepie S, Huguet F, Raffoux E, Thomas X, Leguay T, Marchand T, Isnard F, Charbonnier A, Maury S, Gallego-Hernanz MP, Robillard N, Guillaume T, Peterlin P, Garnier A, Rialland F, Le Houerou C, Goldenberg DM, Wegener WA, Béné MC, Dombret H.

Haematologica. 2017 May;102(5):e184-e186. doi: 10.3324/haematol.2016.159905. Epub 2017 Feb 2. No abstract available.

26.

Immune stimulation during chemotherapy increases incidence of acute graft versus host disease in acute myeloid leukemia: A study on behalf of SFGM-TC and ALFA.

Wang L, Raffoux E, Thomas X, Yakoub-Agha I, Bouhris JH, de Botton S, Michallet M, Quoc SN, Chantepie S, Deconinck E, Caillot D, Turlure P, Vigouroux S, Pigneux A, Huynh A, Malfuson JV, Loschi M, Socie G, Dombret H, de la Tour RP, Cluzeau T.

Leuk Res. 2017 Mar;54:12-16. doi: 10.1016/j.leukres.2017.01.002. Epub 2017 Jan 5.

PMID:
28088653
27.

Fixism and conservation science.

Robert A, Fontaine C, Veron S, Monnet AC, Legrand M, Clavel J, Chantepie S, Couvet D, Ducarme F, Fontaine B, Jiguet F, le Viol I, Rolland J, Sarrazin F, Teplitsky C, Mouchet M.

Conserv Biol. 2017 Aug;31(4):781-788. doi: 10.1111/cobi.12876. Epub 2017 Feb 20.

PMID:
27943401
28.

Blood transfusion in hematologic intensive care unit.

Chantepie SP, Mear JB, Parienti JJ, Bazin A, Benabed K, Cheze S, Gac AC, Johnson-Ansah H, Macro M, Cabrera Q, Reboursiere E, Lancesseur C, Damaj G, Reman O.

Transfusion. 2017 Feb;57(2):296-302. doi: 10.1111/trf.13908. Epub 2016 Nov 11.

PMID:
27861958
29.

[Management of graft failure and erythroblastopenia in patients undergoing allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

Cornillon J, Sicre de Fontbrune F, Chantepie S, Coiteux V, Gauthier J, Masouridi-Levrat S, Pochon C, Terriou L, Yakoub-Agha I, Dalle JH.

Bull Cancer. 2016 Nov;103(11S):S248-S254. doi: 10.1016/j.bulcan.2016.09.004. Epub 2016 Oct 31. Review. French.

PMID:
27810141
30.

Heparan sulfates and the decrease of N-glycans promote early adipogenic differentiation rather than myogenesis of murine myogenic progenitor cells.

Grassot V, Bouchatal A, Da Silva A, Chantepie S, Papy-Garcia D, Maftah A, Gallet PF, Petit JM.

Differentiation. 2017 Jan - Feb;93:15-26. doi: 10.1016/j.diff.2016.08.003. Epub 2016 Sep 28.

PMID:
27689814
31.

Midostaurin in Advanced Systemic Mastocytosis.

Chandesris MO, Damaj G, Canioni D, Brouzes C, Lhermitte L, Hanssens K, Frenzel L, Cherquaoui Z, Durieu I, Durupt S, Gyan E, Beyne-Rauzy O, Launay D, Faure C, Hamidou M, Besnard S, Diouf M, Schiffmann A, Niault M, Jeandel PY, Ranta D, Gressin R, Chantepie S, Barete S, Dubreuil P, Bourget P, Lortholary O, Hermine O; CEREMAST Study Group.

N Engl J Med. 2016 Jun 30;374(26):2605-7. doi: 10.1056/NEJMc1515403. No abstract available.

PMID:
27355555
32.

Rituximab salvage therapy in adults with immune thrombocytopenia: retrospective study on efficacy and safety profiles.

Reboursiere E, Fouques H, Maigne G, Johnson H, Chantepie S, Gac AC, Reman O, Macro M, Benabed K, Troussard X, Damaj G, Cheze S.

Int J Hematol. 2016 Jul;104(1):85-91. doi: 10.1007/s12185-016-1992-4. Epub 2016 Apr 4.

PMID:
27040278
33.

Inter-annual and inter-individual variations in survival exhibit strong seasonality in a hibernating rodent.

Le Cœur C, Chantepie S, Pisanu B, Chapuis JL, Robert A.

Oecologia. 2016 Jul;181(3):795-807. doi: 10.1007/s00442-016-3597-2. Epub 2016 Mar 11.

PMID:
26969470
34.

The prognostic value of hematogones in patients with acute myeloid leukemia.

Chantepie SP, Parienti JJ, Salaun V, Benabed K, Cheze S, Gac AC, Johnson-Ansah H, Macro M, Damaj G, Vilque JP, Reman O.

Am J Hematol. 2016 Jun;91(6):566-70. doi: 10.1002/ajh.24350. Epub 2016 Apr 13.

35.

The level of blast CD33 expression positively impacts the effect of gemtuzumab ozogamicin in patients with acute myeloid leukemia.

Olombel G, Guerin E, Guy J, Perrot JY, Dumezy F, de Labarthe A, Bastie JN, Legrand O, Raffoux E, Plesa A, Wagner-Ballon O, Cornet E, Salaun V, Preudhomme C, Thomas X, Pautas C, Chantepie S, Turlure P, Castaigne S, Dombret H, Feuillard J.

Blood. 2016 Apr 28;127(17):2157-60. doi: 10.1182/blood-2016-01-689976. Epub 2016 Feb 29. No abstract available.

36.

Small, dense high-density lipoprotein 3 particles exhibit defective antioxidative and anti-inflammatory function in familial hypercholesterolemia: Partial correction by low-density lipoprotein apheresis.

Hussein H, Saheb S, Couturier M, Atassi M, Orsoni A, Carrié A, Therond P, Chantepie S, Robillard P, Bruckert E, Chapman MJ, Kontush A.

J Clin Lipidol. 2016 Jan-Feb;10(1):124-33. doi: 10.1016/j.jacl.2015.10.006. Epub 2015 Oct 17.

PMID:
26892129
37.

Does bendamustine impact the mobilization of peripheral blood stem cells? A multicenter retrospective study of 23 cases.

Gac AC, Azar N, Daguindau E, Cartron G, Fornecker LM, Gyan E, Broussais-Guillaumot F, Garidi R, Choufi B, Chantepie SP, Béné MC, Guiéze R, Bijou F, Gressin R, Amorim S, Damaj G.

Leuk Lymphoma. 2016 May;57(5):1149-53. doi: 10.3109/10428194.2016.1140160. Epub 2016 Feb 15.

PMID:
26879408
38.

In vitro and in vivo evaluation of cord blood hematopoietic stem and progenitor cells amplified with glycosaminoglycan mimetic.

Faivre L, Parietti V, Siñeriz F, Chantepie S, Gilbert-Sirieix M, Albanese P, Larghero J, Vanneaux V.

Stem Cell Res Ther. 2016 Jan 7;7:3. doi: 10.1186/s13287-015-0267-y.

39.

Transfusion strategy in hematological intensive care unit: study protocol for a randomized controlled trial.

Chantepie SP, Mear JB, Guittet L, Dervaux B, Marolleau JP, Jardin F, Dutheil JJ, Parienti JJ, Vilque JP, Reman O.

Trials. 2015 Nov 23;16:533. doi: 10.1186/s13063-015-1057-7.

40.

Allogeneic stem cell transplantation (allo-SCT) for de novo Ph+ AML: a study from the French Society of Bone Marrow Transplantation and Cell Therapy.

Chantepie SP, Michallet M, Blaise D, Maury S, Deconinck E, Tabrizi R, Contentin N, Mohty M, Nguyen S, Lioure B, Raus N, Peffault de Latour R, Yakoub-Agha I, Reman O; SFGM-TC group.

Bone Marrow Transplant. 2015 Dec;50(12):1586-8. doi: 10.1038/bmt.2015.206. Epub 2015 Sep 14. No abstract available.

PMID:
26367219
41.

Modulation of inflammation and angiogenesis and changes in ECM GAG-activity via dual delivery of nucleic acids.

Browne S, Monaghan MG, Brauchle E, Berrio DC, Chantepie S, Papy-Garcia D, Schenke-Layland K, Pandit A.

Biomaterials. 2015 Nov;69:133-47. doi: 10.1016/j.biomaterials.2015.08.012. Epub 2015 Aug 6.

PMID:
26283160
42.

Severe chronic primary neutropenia in adults: report on a series of 108 patients.

Sicre de Fontbrune F, Moignet A, Beaupain B, Suarez F, Galicier L, Socié G, Varet B, Coppo P, Michel M, Pautas C, Oksenhendler E, Lengline E, Terriou L, Moreau P, Chantepie S, Casadevall N, Michot JM, Gardembas M, Michallet M, Croisille L, Audrain M, Bellanné-Chantelot C, Donadieu J, Lamy T; French Severe Chronic Neutropenia Registry.

Blood. 2015 Oct 1;126(14):1643-50. doi: 10.1182/blood-2015-03-634493. Epub 2015 Aug 10.

43.

Actuarial senescence can increase the risk of extinction of mammal populations.

Robert A, Chantepie S, Pavard S, Sarrazin F, Teplitsky C.

Ecol Appl. 2015 Jan;25(1):116-24.

PMID:
26255361
44.

Unusual Extramedullary Plasmacytoma: A Rare but Possible Cause of Lymphadenopathy in Chronic Lymphocytic Leukemia.

Chantepie SP, Cabrera Q, Mear JB, Salaun V, Lechapt-Zalcman E, Macro M.

Case Rep Med. 2015;2015:657049. doi: 10.1155/2015/657049. Epub 2015 Jul 7.

45.

Quantitative Genetics of the Aging of Reproductive Traits in the Houbara Bustard.

Chantepie S, Robert A, Sorci G, Hingrat Y, Charmantier A, Leveque G, Lacroix F, Teplitsky C.

PLoS One. 2015 Jul 28;10(7):e0133140. doi: 10.1371/journal.pone.0133140. eCollection 2015.

46.

HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer's disease-related tau pathology.

Sepulveda-Diaz JE, Alavi Naini SM, Huynh MB, Ouidja MO, Yanicostas C, Chantepie S, Villares J, Lamari F, Jospin E, van Kuppevelt TH, Mensah-Nyagan AG, Raisman-Vozari R, Soussi-Yanicostas N, Papy-Garcia D.

Brain. 2015 May;138(Pt 5):1339-54. doi: 10.1093/brain/awv056. Epub 2015 Apr 4.

47.

New methods based on capillary electrophoresis for in vitro evaluation of protein tau phosphorylation by glycogen synthase kinase 3-β.

Nehmé H, Chantepie S, Defert J, Morin P, Papy-Garcia D, Nehmé R.

Anal Bioanal Chem. 2015 Apr;407(10):2821-8. doi: 10.1007/s00216-015-8495-7. Epub 2015 Feb 25.

PMID:
25711986
48.

[Dasatinib-related pneumonia? An example of pharmacovigilance survey].

Audemard A, de la Gastine B, Chantepie S, Verger H, Gac AC, Bergot E, Reman O.

Rev Mal Respir. 2015 Jan;32(1):84-6. doi: 10.1016/j.rmr.2014.08.002. Epub 2014 Sep 26. French. No abstract available.

PMID:
25618211
49.

Gemtuzumab ozogamicin in combination with intensive chemotherapy in relapsed or refractory acute myeloid leukemia.

Chantepie SP, Reboursiere E, Mear JB, Gac AC, Salaun V, Benabed K, Cheze S, Johnsonansah H, Macro M, Vilque JP, Reman O.

Leuk Lymphoma. 2015;56(8):2326-30. doi: 10.3109/10428194.2014.986478. Epub 2015 Jan 21.

PMID:
25393676
50.

Rare but authentic Philadelphia-positive acute myeloblastic leukemia: two case reports and a literature review of characteristics, treatment and outcome.

Reboursiere E, Chantepie S, Gac AC, Reman O.

Hematol Oncol Stem Cell Ther. 2015 Mar;8(1):28-33. doi: 10.1016/j.hemonc.2014.09.002. Epub 2014 Oct 6. Review.

Supplemental Content

Loading ...
Support Center